HR9774FEDERALin_committee

Proposed Faster Approval Process for Over-the-Counter Drugs

Original title: To amend the Federal Food, Drug, and Cosmetic Act to provide for expedited approval of priority nonprescription drugs, and for other purposes.

July 20, 2026

healthcare FDA drug regulation consumer safety

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Where This Stands

Introduced

Committee

Floor Vote

Passed

Signed

Currently in_committee. The next step in the legislative lifecycle is Floor Vote.

Last action

Referred to the House Committee on Energy and Commerce.Jul 20, 2026

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

The Frame

What this does

If passed, this could reduce the time it takes for new over-the-counter medications to become available to consumers, potentially increasing the variety of self-care options in pharmacies.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Consumers

Consumers may gain access to new over-the-counter medications more quickly if the expedited approval process is implemented.

Pharmaceutical companies

Companies developing nonprescription drugs may experience shorter wait times for product approval.

What changed

Current stage: in_committee.

What's next

Floor Vote.

Summary

This bill proposes a new, faster FDA review process for certain to reach store shelves more quickly. It aims to create an expedited pathway for medications that meet specific priority criteria.

Why It Matters

If passed, this could reduce the time it takes for new over-the-counter medications to become available to consumers, potentially increasing the variety of self-care options in pharmacies.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

What does 'expedited approval' mean for consumers?

It means the FDA would have a faster, prioritized process for reviewing and potentially approving certain , which could lead to them being available for purchase sooner.

Does this bill change safety standards?

The text provided does not specify changes to safety standards, only that it creates an expedited pathway for priority drugs.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift80% confidence

Regulatory Acceleration

The bill signals a legislative intent to prioritize speed in the nonprescription drug market, potentially shifting FDA resource allocation.

Federal Food, Drug, and Cosmetic Act

Connected Entities

otherFederal Food, Drug, and Cosmetic Act“The existing law that this bill seeks to amend.”Map →

organizationHouse Committee on Energy and Commerce“The committee currently reviewing the bill.”Map →

Analysis Score

0–100

Significance60
How much this matters to a regular citizen
Controversy20
Intensity of disagreement among stakeholders
Entertainment5
Compellingness for a non-policy-wonk reader
Buzz15
Current news / social attention level

Publisher tools